200
Participants
Start Date
May 31, 1998
Primary Completion Date
October 31, 2011
Study Completion Date
October 31, 2011
Orlistat
Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.
Placebo
Subjects receive drug for 6 months plus a 12 week intensive behavioral weight los program. Subjects return for monthly visits for 3 more months.
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Roche Pharma AG
INDUSTRY
Jack Yanovski
NIH